meglumine has been researched along with Hamartoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drop, SL; Meradji, M; Oostdijk, W; Robben, SG; Tanghe, HL; Vielvoye, GJ | 1 |
| Brown, JJ; Eilenberg, SS; Heiken, JP; Lee, JK; Mirowitz, SA | 1 |
1 trial(s) available for meglumine and Hamartoma
| Article | Year |
|---|---|
Idiopathic isosexual central precocious puberty: magnetic resonance findings in 30 patients.
Topics: Adolescent; Brain; Child; Child, Preschool; Drug Combinations; Female; Gadolinium DTPA; Hamartoma; Humans; Hypothalamic Diseases; Infant; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Prospective Studies; Puberty, Precocious; Tuber Cinereum | 1995 |
1 other study(ies) available for meglumine and Hamartoma
| Article | Year |
|---|---|
Evaluation of renal masses with contrast-enhanced rapid acquisition spin echo MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Hamartoma; Humans; Kidney; Kidney Diseases, Cystic; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Pentetic Acid; ROC Curve; Time Factors; Tomography, X-Ray Computed | 1993 |